SCHEMBL7868381

SCHEMBL7868381

O=C(CS(=O)(=O)[O-])c1ccccc1.[Na+]

nearest known ligand 0.56

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 2/20 0.46
CA4 known ✓ P22748 2/20 0.46
CA12 known ✓ O43570 1/20 0.43
CA1 known ✓ P00915 1/20 0.43
RECQL P46063 2/20 0.56
MAPK1 P28482 2/20 0.52
MAPT P10636 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
CYP3A4 P08684 2/20 0.52
HPGD P15428 2/20 0.52
KDM4E B2RXH2 1/20 0.52
MEN1 O00255 1/20 0.52
ALOX15 P16050 1/20 0.52
CES1 P23141 1/20 0.52
KMT2A Q03164 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
PTPN1 P18031 2/20 0.50
ERCC5 P28715 1/20 0.50
FEN1 P39748 1/20 0.50
ALDH1A1 P00352 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1516246 0.80 MAPK1 (0.58) RECQLMAPK1MAPTTDP1CYP3A4
SCHEMBL10424359 0.80 HSD11B1 (0.62) RECQLMAPK1MAPTTDP1CYP3A4
SCHEMBL137832 0.78 MAPK1 (0.56) RECQLMAPK1MAPTTDP1CYP3A4
SCHEMBL9488123 0.78 MAOA (0.42) RECQLMAPK1MAPTTDP1CYP3A4
SCHEMBL2188285 0.77 MAPT (0.54) RECQLMAPK1MAPTTDP1CYP3A4
SCHEMBL7149069 0.77 MAPK1 (0.54) RECQLMAPK1MAPTTDP1CYP3A4
SCHEMBL260911 0.77 ALDH1A1 (0.56) RECQLMAPK1MAPTTDP1CYP3A4
SCHEMBL9197870 0.77 MAPK1 (0.54) RECQLMAPK1MAPTTDP1CYP3A4
SCHEMBL7868384 0.77 MAPK1 (0.54) RECQLMAPK1MAPTTDP1CYP3A4
SCHEMBL15791249 0.77 MAPK1 (0.54) RECQLMAPK1MAPTTDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111377995-B Preparation method of prednisolone sodium benzoylsulfonate 天津药业研究院股份有限公司 2022-09-09 CN disclosed
US-10711021-B2 Metal oxide-organic hybrid materials for heterogeneous catalysis and methods of making and using thereof YALE UNIVERSITY (US) 2020-07-14 US disclosed
US-10081650-B2 Metal oxide-organic hybrid materials for heterogeneous catalysis and methods of making and using thereof YALE UNIVERSITY (US) 2018-09-25 US disclosed
US-20160152648-A1 METAL OXIDE-ORGANIC HYBRID MATERIALS FOR HETEROGENEOUS CATALYSIS AND METHODS OF MAKING AND USING THEREOF YALE UNIVERSITY 2016-06-02 US disclosed
US-20150065339-A1 METAL OXIDE-ORGANIC HYBRID MATERIALS FOR HETEROGENEOUS CATALYSIS AND METHODS OF MAKING AND USING THEREOF NATIONAL SCIENCE FOUNDATION 2015-03-05 US disclosed
US-6326512-B1 HYDROGENATION A B-KETOSULFONIC ACID COMPOUND PRESIDENT OF NAGOYA UNIVERSITY (JP) 2001-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10711021-B2 Metal oxide-organic hybrid materials for heterogeneous catalysis and methods of making and using thereof SOD1, SOD3, AS3MT CA2 5/4885CA4 24/4885CA12 9/4885
US-10081650-B2 Metal oxide-organic hybrid materials for heterogeneous catalysis and methods of making and using thereof SOD1, SOD3, AS3MT CA2 5/4885CA4 24/4885CA12 9/4885
US-20160152648-A1 METAL OXIDE-ORGANIC HYBRID MATERIALS FOR HETEROGENEOUS CATALYSIS AND METHODS OF MAKING AND USING THEREOF SOD1, SOD3, AS3MT CA2 5/4885CA4 24/4885CA12 9/4885
US-20150065339-A1 METAL OXIDE-ORGANIC HYBRID MATERIALS FOR HETEROGENEOUS CATALYSIS AND METHODS OF MAKING AND USING THEREOF SOD1, SOD3, AS3MT CA2 5/4885CA4 24/4885CA12 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.